LILRB2

Leukocyte immunoglobulin-like receptor B2

Also known as: LILRB2, ILT4, CD85d, LIR2, MIR10

Biology & Mechanism

LILRB2 is an inhibitory receptor expressed on myeloid cells including microglia that binds APOE and other ligands to suppress immune activation. LILRB2 may mediate some of the immunosuppressive effects of APOE on microglial function. Variants near the LILRB2 locus have been identified in Alzheimer's disease GWAS. Its interaction with APOE4 may contribute to impaired microglial responses in high-risk individuals.

Open Questions

  • Does LILRB2-APOE4 interaction directly impair microglial phagocytosis in human brain?
  • Can LILRB2 blockade rescue APOE4-impaired microglial function?
  • What is the full spectrum of LILRB2 ligands in the brain parenchyma?

Sources

Evidence Status

human geneticshuman tissuesingle-cell RNA-seqin vitro assay

Disease Links

  • Alzheimer's disease

Related Targets

Last reviewed: June 1, 2026